Mark For: COBALT™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 90722349 |
Mark Literal Elements | COBALT |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | NEW APPLICATION PROCESSING 2021-05-22 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Tiffany D. Gehrke |
Attorney Docket Number | 33324/60042 |
2021-05-19 | Application Filed |
2021-05-22 | Location: NEW APPLICATION PROCESSING |
2021-05-22 | Status: Live/Pending |
2021-05-22 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
2021-05-22 | Transaction Date |
Party: | Crispr Therapeutics AG |
Address | Baarerstrasse 14 ZUG V8 SWITZERLAND CH-6300 |
Legal Entity Type | Aktiengesellschaft |
Legal Entity State | SWITZERLAND |
Application | MULTI | 2021-05-19 |
Drawing | JPEG | 2021-05-19 |
IC 005. US 005 006 018 044 046 051 052. G & S: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
IC 042. US 100 101. G & S: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2021-05-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.